BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15086425)

  • 1. Non-myeloablative stem cell transplantation for severe combined immunodeficiency--Omenn syndrome.
    Rossi G; Zecca M; Giorgiani G; Bonetti F; De Stefano P; Locatelli F
    Br J Haematol; 2004 May; 125(3):406-7. PubMed ID: 15086425
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
    Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
    Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late immunologic and clinical outcomes for children with SCID.
    Neven B; Cavazanna-Calvo M; Fischer A
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):76-8. PubMed ID: 19418624
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA-haploidentical donor transplantation in severe combined immunodeficiency.
    Friedrich W; Hönig M
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):31-44. PubMed ID: 20113885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saving the red baby: successful allogeneic cord blood transplantation in Omenn syndrome.
    Schönberger S; Ott H; Gudowius S; Wüller S; Baron JM; Merk HF; Lassay L; Megahed M; Feyen O; Laws HJ; Dilloo D; Borkhardt A; Niehues T
    Clin Immunol; 2009 Mar; 130(3):259-63. PubMed ID: 19064334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
    Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell transplantation for profound T-cell deficiency (combined immunodeficiency).
    Roifman CM
    Immunol Allergy Clin North Am; 2010 May; 30(2):209-19. PubMed ID: 20493397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
    Ringdén O; Svenberg P; Le Blanc K; Mattsson J; Remberger M
    Bone Marrow Transplant; 2006 Aug; 38(4):321-2. PubMed ID: 16819434
    [No Abstract]   [Full Text] [Related]  

  • 9. Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning.
    Veys P; Rao K; Amrolia P
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S45-7. PubMed ID: 15812530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prenatal and postnatal transplantation of hematopoietic stem cells in children with primary immunodeficiency].
    Porta F; Lanfranchi A; Verardi R; Mazzolari E; Verzeri U; Tettoni K; Ugazio AG
    Ann Ist Super Sanita; 1999; 35(2):315-28. PubMed ID: 10645667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in two severe combined immunodeficiency disease patients posthaematopoietic stem cell transplantation.
    Bredius RG; Ouachee M; van Brempt R; Bökenkamp R; Lankester AC; Dolman KM; Egeler RM; Fischer A
    Br J Haematol; 2004 May; 125(3):405-6. PubMed ID: 15086424
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation for primary immunodeficiency disease.
    Dvorak CC; Cowan MJ
    Bone Marrow Transplant; 2008 Jan; 41(2):119-26. PubMed ID: 17968328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double cure: Omenn syndrome and β thalassaemia successfully treated with mismatched unrelated donor transplantation.
    Wootten V; Goulden N; Veys P; Qasim W
    Bone Marrow Transplant; 2012 Apr; 47(4):589-90. PubMed ID: 21602897
    [No Abstract]   [Full Text] [Related]  

  • 16. An infant with severe combined immunodeficiency syndrome, an alpha-thalassemia trait and renal Fanconi syndrome.
    van de Moesdijk D; van Weel-Sipman MH
    Bone Marrow Transplant; 2000 Jul; 26(1):97-9. PubMed ID: 10918411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.
    Mori T; Aisa Y; Yokoyama A; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Kato J; Watanabe R; Takayama N; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2007 Feb; 39(4):217-21. PubMed ID: 17220902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
    Burt RK; Marmont A; Oyama Y; Slavin S; Arnold R; Hiepe F; Fassas A; Snowden J; Schuening F; Myint H; Patel DD; Collier D; Heslop H; Krance R; Statkute L; Verda L; Traynor A; Kozak T; Hintzen RQ; Rose JW; Voltarelli J; Loh Y; Territo M; Cohen BA; Craig RM; Varga J; Barr WG
    Arthritis Rheum; 2006 Dec; 54(12):3750-60. PubMed ID: 17133541
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation.
    Seidel MG; Fritsch G; Matthes-Martin S; Lawitschka A; Lion T; Pötschger U; Rosenmayr A; Fischer G; Gadner H; Peters C
    Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in hematopoietic stem cell transplantation for primary immunodeficiency.
    Gennery AR; Cant AJ
    Immunol Allergy Clin North Am; 2008 May; 28(2):439-56, x-xi. PubMed ID: 18424341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.